Up a level |
Swen, Jesse J, van der Wouden, Cathelijne H, Manson, Lisanne En, Abdullah-Koolmees, Heshu, Blagec, Kathrin, Blagus, Tanja, Böhringer, Stefan, Cambon-Thomsen, Anne, Cecchin, Erika, Cheung, Ka-Chun et al (show 32 more authors)
(2023)
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Lancet (London, England), 401 (10374).
pp. 347-356.
van der Wouden, Cathelijne H, Bohringer, Stefan, Cecchin, Erika, Cheung, Ka-Chun, Lucia Davila-Fajardo, Cristina, Deneer, Vera HM, Dolzan, Vita, Ingelman-Sundberg, Magnus, Jonsson, Siv, Karlsson, Mats O et al (show 17 more authors)
(2020)
Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.
Pharmacogenetics and Genomics, 30 (6).
pp. 131-144.
Hurkmans, Evelien GE, Klumpers, Marije J, Dello Russo, Cinzia ORCID: 0000-0002-2538-3832, De Witte, Ward, Guchelaar, Henk-Jan, Gelderblom, Hans, Cleton-Jansen, Anne-Marie, Vermeulen, Sita H, Kaal, Suzanne, van der Graaf, Winette TA et al (show 22 more authors)
(2023)
Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.
Frontiers in pharmacology, 13.
p. 980309.
Blagec, Kathrin, Swen, Jesse J, Koopmann, Rudolf, Cheung, Ka-Chun, Crommentuijn-van Rhenen, Mandy, Holsappel, Inge, Konta, Lidija, Ott, Simon, Steinberger, Daniela, Xu, Hong et al (show 10 more authors)
(2022)
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
PloS one, 17 (6).
e0268534-e0268534.